Reviews Records of Dolutegravir and Lamivudine Use in Untreated HIV Patients
Looks back at medical charts of adults with HIV starting dolutegravir and lamivudine.
Plain-language title generated from the registry record
Registry title: Efficacy and Safety of DTG/3TC in Treatment-naïve HIV-1 Infected Patients
Key facts
- Where
- Daejeon, South KoreaSee the site
Where in South Korea
- Chungnam National University Hospital, 282 Munwha-roDaejeon, South KoreaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chungnam National University Hospital
- Trial code
- NCT06928090
- Record updated
- 15 April 2025
- Original description
Non-interventional, retrospective, single arm study of individuals who have initiated a DTG/3TC regimen. Medical chart will be reviewed by the investigators. Naive subjects will be identified by the clinic database as having initiated DTG/3TC.Read full original descriptionShow less
A Retrospective Observational Study of Efficacy and Safety of DTG/3TC(Dolutegravir/Lamivudine) in Treatment-naïve HIV-1 Infected Patients From at Real-life Cohort in Korea
Non-interventional, retrospective, single arm study of individuals who have initiated a DTG/3TC regimen. Medical chart will be reviewed by the investigators. Naive subjects will be identified by the clinic database as having initiated DTG/3TC.
Inclusion: HIV-1 diagnosis; Prescribed DTG/3TC alone to manage HIV-1 infection as initial antiretroviral treatment at the study centers.
Exclusion: Previous antiretroviral treatment; HIV-2 diagnosis.